Abstract:Seaweeds are a treasure trove of natural secondary metabolites. Terpenoids extracted from seaweeds are shown to possess a variety of antitumor cellular activities. However, due to the complex and diverse structures of terpenoids, their therapeutic targets and complex mechanisms of action have not been clarified. The present study summarises the research on terpenoids from seaweeds in oncological diseases over the last 20 years. Terpenoids show different degrees of inhibitory effects on different types of tumor cells, suggesting that terpenoids in seaweeds may have potential antitumor disease potential. Terpenoids with potential antitumor activity and their mechanism of action are investigated using network pharmacology. A total of 125 terpenoids and 286 targets are obtained. Proto-oncogene tyrosine-protein kinase Src(SRC), Signal transducer and activator of transcription 3 (STAT3), Mitogen-activated protein kinase (MAPK3, MAPK1), Heat shock protein HSP 90-alpha (HSP90AA1), Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA), and RAC-alpha serine/threonine-protein kinase (AKT1) are defined as core targets. According to GO function and Kyoto encyclopedia of genes and genomes(KEGG) enrichment analysis, terpenoids may affect the Phoshatidylinositol 3'-kinase (PI3K)-Akt signaling pathway, Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor resistance, Prostate cancer, MAPK signaling pathway, and Proteoglycans in cancer. In addition, the molecular docking results show that the selected terpenoids are all able to bind strongly to the active protein. Terpenoids may slow down the progression of cancer by controlling apoptosis, proliferation, and protein and enzyme binding.

MAPK signaling pathway-targeted marine compounds in cancer therapy

Research Progress in the Mechanism of Molecular Targeted Anti-tumor Drugs

The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy

Development of Marine-Derived Compounds for Cancer Therapy

Natural products targeting the MAPK-signaling pathway in cancer: overview

Non-coding RNA-related antitumor mechanisms of marine-derived agents

Marine Power on Cancer: Drugs, Lead Compounds, and Mechanisms

Antitumor Potential of Marine Natural Products: A Mechanistic Investigation.

Extracellular-signal-regulated kinase/mitogen-activated protein kinase signaling as a target for cancer therapy: an updated review

Natural compounds modulating mitophagy: Implications for cancer therapy

Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer therapy

MAPK Signaling Pathway in Oral Squamous Cell Carcinoma: Biological Function and Targeted Therapy

Antitumor Activity and Mechanism of Terpenoids in Seaweeds Based on Literature Review and Network Pharmacology

Marine-Derived Anticancer Agents Targeting Apoptotic Pathways: Exploring the Depths for Novel Cancer Therapies

Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities

Natural Marine Products: Anti-Colorectal Cancer In Vitro and In Vivo

Targeting Cellular Apoptotic Pathway with Peptides from Marine Organisms

Advances in anti-cancer effects and underlying mechanisms of marine algae polysaccharides

Mitogen-activated protein kinase signaling pathway and invasion and metastasis of gastric cancer

Bioactive compounds from marine invertebrates as potent anticancer drugs: the possible pharmacophores modulating cell death pathways

Targeting PI3K/Akt signal transduction for cancer therapy